Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04499807 · ClinicalTrials.gov registry record · NA
Accuracy of Rhythm Detection by a Wearable Smart Watch for Cardiac Arrhythmias (The WATCH-RHYTHM Study)
A NA study, sponsored by Kansas City Heart Rhythm Research Foundation.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT04499807: Clinical Trial NA study, sponsored by Kansas City Heart Rhythm Research Foundation.
NCT04499807 is a NA study that was terminated before completion, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04499807, a NA study, was terminated before completion, sponsored by Kansas City Heart Rhythm Research Foundation.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
It is an attempt to see the reliability of the Wearable Smart Watch in identifying atrial fibrillation and other arrhythmias compared to the data detected from ILRs.
Primary Outcome
Heart rate data generated by Smart Watch is used to assess their rhythm as confirmed by the ILR done during the same time.
Interventions
- OTHER AFib detection with wearable smart watch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-01-06 |
| Est. Completion | 2021-03-16 |
| Phase | NA |
Why NCT04499807 stopped before completion
NCT04499807 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which AFib detection with wearable smart watch is the first listed.
NCT04499807 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04499807 about?
NCT04499807 is a clinical study titled "Accuracy of Rhythm Detection by a Wearable Smart Watch for Cardiac Arrhythmias (The WATCH-RHYTHM Study)". It is an attempt to see the reliability of the Wearable Smart Watch in identifying atrial fibrillation and other arrhythmias compared to the data detected from ILRs.
What is the current status of trial NCT04499807?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2021-01-06. Estimated completion is 2021-03-16.
What interventions are being tested in trial NCT04499807?
The interventions under investigation include: AFib detection with wearable smart watch (OTHER).
Who is sponsoring clinical trial NCT04499807?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04499807's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI